Personal History:Dr. Streeten received her medical degree from Albany Medical College in Albany, NY. She completed her internship and residency in Internal Medicine and a fellowship in Medical Genetics at The Johns Hopkins Hospital. This was followed by a fellowship in Endocrinology at the NIH, in the Metabolic Diseases Branch of NIDDK. After completing her training in 1990, Dr. Streeten had a private practice of endocrinology and was on the part-time faculty in the Endocrinology division at Johns Hopkins. In 1998, she joined the faculty at UMMS in the division of Endocrinology, Diabetes & Nutrition, where she is to date. In 2005, she co-founded the Adult Genetics Clinic and received a secondary appointment in the Genetics Division of the Pediatric Department. Dr. Streeten is board-certified in Internal Medicine, Endocrinology and Clinical Genetics.
Dr. Streeten's research interests include the study of genetic factors contributing to bone health and vitamin D metabolism, primary and secondary hyperparathyroidism and treatment of Osteoporosis-pseudoglioma (OPPG) syndrome. She has been a co-investigator in the Amish Family Osteoporosis Study since 1998. Current research projects include (1) The Amish Family Osteoporosis Study (a study to look for genes related to bone health), (2) The "Sunshine Study" (a study to evaluate individual variability in Vitamin D production), (3) OPPG treatment, and (4) Myozyme Temporary Access Program (a study of Myozyme treatment for adults with Pompe disease).
Clinical Speciality:Dr. Streeten's subspecialty within endocrinology is in metabolic bone and mineral diseases. She runs the Osteoporosis and Metabolic Bone Diseases clinics at both UMMS and the Baltimore VA. Adult patients seen in the metabolic bone clinics include those with osteoporosis, Paget disease of bone, renal osteodystrophy, parathyroid disorders, non-PTH mediated hypercalcemia, kidney stones, vitamin D disorders, osteogenesis imperfecta, hypophosphatemic rickets and oncogenic osteomalacia.
On the inpatient side, Dr. Streeten introduced a clinical initiative at UMMS in 11/01 to improve the recognition and treatment of osteoporosis in inpatients hospitalized for treatment of fragility fractures. This Osteoporosis Consultation program, in collaboration with the Orthopaedics department at UMMS, revealed that fracture patients who are started on treatment for osteoporosis during their inpatient stay generally remain on the treatment well after discharge.
Dr. Streeten also maintains a stronginterest in general endocrinology and sees patients in the UMMS Joslin Center for Diabetes.